Modifiable risk factors and prevention of dementia what is the latest evidence?

JAMA Internal Medicine

Volumn 178, Issue 2, 2018, Pages 281-282

  Yaffe, Kristine ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATTRIBUTABLE RISK; BLOOD PRESSURE REGULATION; DEMENTIA; DIABETES MELLITUS; DISEASE COURSE; EDUCATIONAL STATUS; EVIDENCE BASED PRACTICE; HEALTH CARE COST; HEARING IMPAIRMENT; HUMAN; HYPERTENSION; LATE LIFE DEPRESSION; MILD COGNITIVE IMPAIRMENT; NEUROPROTECTION; PHYSICAL ACTIVITY; PHYSICAL INACTIVITY; PRIORITY JOURNAL; PUBLIC HEALTH CAMPAIGN; RISK FACTOR; SHORT SURVEY; SMOKING; SOCIAL ISOLATION; COGNITION; PATHOPHYSIOLOGY; PHYSIOLOGY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARDS;

COGNITION; DEMENTIA; HUMANS; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 85041643219     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2017.7299     Document Type: Short Survey

References (7)

1. Leshner AI, Landis S, Stroud C, Downey A. Preventing Cognitive Decline and Dementia: AWay Forward. Washington, DC: National Academy of Sciences; 2017.
2. Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and care (published online July 19, 2017). Lancet. doi:10. 1016/S0140-6736(17)31363-6
3. Alzheimer's Association. 2017 Alzheimer's disease facts and figures. Alzheimers Dement. 2017; 13(4):325-373.
4. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 1998;88(9):1337-1342.
5. Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. Lancet Neurol. 2014;13(8): 788-794.
6. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011;10(9):819-828.
7. Satizabal CL, Beiser AS, Chouraki V, Chêne G, Dufouil C, Seshadri S. Incidence of dementia over three decades in the Framingham Heart Study. N Engl J Med. 2016;374(6):523-532.